-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G8vTd4H/agxXZBLuUF3W/ugVv3ElOtADUo2/0i18cJg4oDbhSXRSOQLPF0mnU58R O9nVs2o2rl3geVM5/4U5+Q== 0001157523-10-000955.txt : 20100217 0001157523-10-000955.hdr.sgml : 20100217 20100217121014 ACCESSION NUMBER: 0001157523-10-000955 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100216 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100217 DATE AS OF CHANGE: 20100217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 10611810 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ BLDG 600 5TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 MAIL ADDRESS: STREET 1: ONE KENDALL SQ BLDG 600 STREET 2: 5TH FL CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 8-K 1 a6182179.htm DYAX CORP. 8-K a6182179.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C.  20549
 
FORM 8-K
 
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported):  February 16, 2010
 
 
DYAX CORP.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
000-24537
04-3053198
(State or Other Jurisdiction of
Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
300 Technology Square
Cambridge, MA  02139
(Address of Principal Executive Offices)  (Zip Code)
 
 
(617) 225-2500
(Registrant's telephone number, including area code)
 
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
Item 1.01.
Entry into a Material Definitive Agreement.
 
On February 16, 2010, Dyax Corp. entered into an amendment to its existing equity line of credit arrangement with Azimuth Opportunity Ltd., which was originally entered into on October 30, 2008.  The amendment extends the investment period from April 30, 2010 to January 7, 2011 and increases the limit per draw down under the line from $7,750,000 to $8,250,000.
 
The foregoing description is qualified in its entirety by reference to Amendment No. 1 to the Common Stock Purchase Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated by reference herein.
 
 
Item 9.01.
Financial Statements and Exhibits.
     
 
(d)
Exhibits.
     
 
10.1
Amendment No. 1 to Common Stock Purchase Agreement between Dyax Corp. and Azimuth Opportunity, Ltd. dated February 16, 2010.
 
 
2

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
DYAX CORP.
 
 
 
 
Dated:
February 17, 2010
By:
/s/ Ivana Magovčević-Liebisch
 
 
   
Ivana Magovčević-Liebisch
 
 
   
Executive Vice President Corporate
 
 
   
Development and General Counsel
 
 
 
3

 
EXHIBIT INDEX
 
 
Exhibit
   
    No.     
 
Description
     
   10.1
 
Amendment No. 1 to Common Stock Purchase Agreement between Dyax Corp. and Azimuth Opportunity, Ltd. dated February 16, 2010.
 
 
 
4
EX-10.1 2 a6182179ex10-1.htm EXHIBIT 10.1 a6182179ex10-1.htm
Exhibit 10.1
 
 
AMENDMENT NO. 1 TO
COMMON STOCK PURCHASE AGREEMENT
 
This Amendment No. 1 (this “Amendment”) to that certain Common Stock Purchase Agreement, dated October 30, 2008 (the “Agreement”), by and between Dyax Corp., a  Delaware corporation (the “Company”), and Azimuth Opportunity Ltd., an international business company incorporated under the laws of the British Virgin Islands (the “Investor”), is entered into as of February 16, 2010 (the “Amendment Date”).  Capitalized terms not otherwise defined herein shall have the meaning set forth in the Agreement.
 
Recitals
 
Whereas, Section 2.2 of the Agreement provides in part that the applicable Discount Price shall be determined in accordance with the price and share amount parameters as set forth in the pricing grid table set forth therein, or such other parameters mutually agreed upon by the Investor and the Company;
 
Whereas, Section 7.1 of the Agreement provides in part that, unless earlier terminated, the Agreement shall terminate automatically on the earliest of (i) the first day of the month next following the 18-month anniversary of the Effective Date, (ii) the date that the entire dollar amount of Shares registered under the Registration Statement have been issued and sold and (iii) the date the Investor shall have purchased the Total Commitment of shares of Common Stock (subject in all cases to the Trading Market Limit);
 
Whereas, the Agreement remains in full force and effect;
 
Whereas, Section 9.3 of the Agreement provides that the Agreement may be amended by a written instrument signed by the Company and the Investor; and
 
Whereas, the Company and the Investor now desire to amend the Agreement as set forth herein.
 
Agreement
 
Now, Therefore, in consideration of the mutual promises, representations, warranties, covenants and conditions set forth in the Agreement and this Amendment, the receipt and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:
 
1.           Amendment of Section 2.2.  Effective as of the Amendment Date, Section 2.2 of the Agreement shall be amended and restated in its entirety as follows:
 
Section 2.2.     Fixed Requests.  From time to time during the Investment Period, the Company may in its sole discretion deliver to the Investor a Fixed Request Notice for a specified Fixed Amount Requested, and the applicable discount price (the “Discount Price”) shall be determined, in accordance with the price and share amount parameters as set forth below or such other parameters mutually agreed upon by the Investor and the Company, and upon the terms and subject to the conditions of this Agreement, the Investor shall purchase from the Company the Shares subject to such Fixed Request Notice; provided, however, that (i) if an ex-dividend date is established by the Trading Market in respect of the Common Stock on or between the first Trading Day of the applicable Pricing Period and the applicable Settlement Date, the Discount Price shall be reduced by the per share dividend amount and (ii) the Company may not deliver any single Fixed Request Notice for a Fixed Amount Requested in excess of the lesser of (a) the amount in the applicable Fixed Amount Requested column below and (b) 2.5% of the Market Capitalization:
 
 

 
Threshold Price
Fixed Amount Requested
Discount Price
     
Equal to or greater than $10.00
Not to exceed $8,250,000
95.950% of the VWAP
     
Equal to or greater than $9.00 and less than $10.00
Not to exceed $7,500,000
95.850% of the VWAP
     
Equal to or greater than $8.00 and less than $9.00
Not to exceed $6,750,000
95.750% of the VWAP
     
Equal to or greater than $7.00 and less than $8.00
Not to exceed $6,000,000
95.375% of the VWAP
     
Equal to or greater than $6.00 and less than $7.00
Not to exceed $5,250,000
95.125% of the VWAP
     
Equal to or greater than $5.00 and less than $6.00
Not to exceed $4,500,000
94.750% of the VWAP
     
Equal to or greater than $4.00 and less than $5.00
Not to exceed $3,750,000
94.500% of the VWAP
     
Equal to or greater than $3.00 and less than $4.00
Not to exceed $3,000,000
94.250% of the VWAP
     
Equal to or greater than $2.00 and less than $3.00
Not to exceed $2,250,000
93.750% of the VWAP
 
Anything to the contrary in this Agreement notwithstanding, at no time shall the Investor be required to purchase more than $8,250,000 worth of Common Stock in respect of any Pricing Period (not including Common Stock subject to any Optional Amount).  The date on which the Company delivers any Fixed Request Notice in accordance with this Section 2.2 hereinafter shall be referred to as a “Fixed Request Exercise Date”.
 
2.           Amendment of Section 7.1.  Effective as of the Amendment Date, Section 7.1 of the Agreement shall be amended to replace the first sentence thereof with the following:
 
Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest of (i) January 7, 2011 (the “Investment Period”), (ii) the date that the entire dollar amount of Shares registered under the Registration Statement have been issued and sold and (iii) the date the Investor shall have purchased the Total Commitment of shares of Common Stock (subject in all cases to the Trading Market Limit).
 
 
2

 
3.           Continuing Effect of Agreement.  Except as expressly set forth in this Amendment, all other provisions of the Agreement remain in full force and effect.
 
4.           Governing Law.  This Amendment shall be governed by and construed in accordance with the internal procedure and substantive laws of the State of New York, without giving effect to the choice of law provisions of such state.
 
5.           Counterparts.  This Amendment may be executed in counterparts, all of which taken together shall constitute one and the same original and binding instrument and shall become effective when all counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties hereto need not sign the same counterpart.
 

 
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]
 
 
3


 
In Witness Whereof, the parties hereto have caused this Amendment No. 1 to the Agreement to be executed and delivered as of the Amendment Date.
 
 
  Company:   DYAX CORP.  
       
       
 
By:
/s/ George Migausky
 
   
Name:  George Migausky
 
   
Title:    Chief Financial Officer
 
       
 
 
 
 
Investor:  AZIMUTH OPPORTUNITY LTD.
 
       
       
 
By:
/s/ Dierdre M. McCoy  
   
Name: Dierdre M. McCoy
 
   
Title: Corporate Secretary
 
       
 
 
 
4
-----END PRIVACY-ENHANCED MESSAGE-----